tiprankstipranks
Advertisement
Advertisement

DE:5IU Stock Latest News

Isofol Extends Arfolitixorin Rights Into Autism While Keeping Cancer Focus
Company AnnouncementsIsofol Extends Arfolitixorin Rights Into Autism While Keeping Cancer Focus
11d ago
Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise
PremiumCompany Announcements
Isofol Sets TO1 Warrant Price and Exercise Window, Targets SEK 19 Million Raise
16d ago
Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise
PremiumCompany Announcements
Isofol Secures Stakeholder Support Covering 42% of Upcoming TO1 Warrant Exercise
18d ago
Isofol to Add Major Shareholder Christian Haglund to Expanded Board
PremiumCompany Announcements
Isofol to Add Major Shareholder Christian Haglund to Expanded Board
20d ago
Isofol to Showcase Cancer Drug Candidate at Key March Investor Events
PremiumCompany Announcements
Isofol to Showcase Cancer Drug Candidate at Key March Investor Events
26d ago
Isofol Reports Strong Early Data for Arfolitixorin in Difficult-to-Treat Colorectal Cancer
PremiumCompany AnnouncementsIsofol Reports Strong Early Data for Arfolitixorin in Difficult-to-Treat Colorectal Cancer
1M ago
Isofol strengthens arfolitixorin program with new EU patent and advancing trials
Premium
Company Announcements
Isofol strengthens arfolitixorin program with new EU patent and advancing trials
1M ago
Isofol Showcases Arfolitixorin Trial Design at ASCO GI as Phase Ib/II Study Advances
Premium
Company Announcements
Isofol Showcases Arfolitixorin Trial Design at ASCO GI as Phase Ib/II Study Advances
3M ago
Isofol Medical to Showcase Arfolitixorin at Upcoming Investor Meetings
PremiumCompany Announcements
Isofol Medical to Showcase Arfolitixorin at Upcoming Investor Meetings
4M ago
Isofol Medical Secures New Patent for Cancer Drug Candidate Arfolitixorin
PremiumCompany Announcements
Isofol Medical Secures New Patent for Cancer Drug Candidate Arfolitixorin
5M ago
Isofol Medical AB Reports Key Developments in Interim Report
PremiumCompany Announcements
Isofol Medical AB Reports Key Developments in Interim Report
5M ago
Isofol Medical AB Appoints Nomination Committee for 2026 AGM
PremiumCompany Announcements
Isofol Medical AB Appoints Nomination Committee for 2026 AGM
5M ago
Isofol Medical AB to Host Investor Meeting on Arfolitixorin Progress
PremiumCompany AnnouncementsIsofol Medical AB to Host Investor Meeting on Arfolitixorin Progress
5M ago
Isofol Medical AB to Present at ESMO Cancer Congress
Premium
Company Announcements
Isofol Medical AB to Present at ESMO Cancer Congress
5M ago
Isofol Medical Advances Arfolitixorin Clinical Study with Promising Results
Premium
Company Announcements
Isofol Medical Advances Arfolitixorin Clinical Study with Promising Results
6M ago
Isofol Completes Share Transfer to Solasia Pharma, Strengthening Partnership
PremiumCompany Announcements
Isofol Completes Share Transfer to Solasia Pharma, Strengthening Partnership
6M ago
Isofol Medical AB Strengthens Financial Position Amid Ongoing Clinical Developments
PremiumCompany Announcements
Isofol Medical AB Strengthens Financial Position Amid Ongoing Clinical Developments
7M ago
Isofol Medical to Present Q2 2025 Interim Report
PremiumCompany Announcements
Isofol Medical to Present Q2 2025 Interim Report
7M ago
Isofol Medical Announces Change in Shares and Votes
PremiumCompany Announcements
Isofol Medical Announces Change in Shares and Votes
8M ago
Isofol Medical Secures FDA Support for Arfolitixorin Development
PremiumCompany AnnouncementsIsofol Medical Secures FDA Support for Arfolitixorin Development
9M ago
Isofol Medical’s Rights Issue Fully Subscribed, Boosting Financial Position
Premium
Company Announcements
Isofol Medical’s Rights Issue Fully Subscribed, Boosting Financial Position
9M ago
Isofol Medical AB Announces Fully Guaranteed Rights Issue
Premium
Company Announcements
Isofol Medical AB Announces Fully Guaranteed Rights Issue
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >